AUA 2016: Sexual Dysfunction in Neurogenic Disorders and their treatment



San Diego, CA USA (UroToday.com): Dr Elliott presented an informative lecture on sexual health in patients with neurogenic lower urinary tract dysfunction (NLUTD).  The primary take away was the importance of sexual health in this population and methods (e.g. drugs, device aids) that can be used to promote satisfying sex in this population.
Read more ...

AUA 2016: Utilization trends of advanced practice providers for office procedural urologic care in the United States from 2003 to 2014


A recent AUA white paper outlined the expanding role of advanced practice providers (NPs and Pas) in urology practices nationwide.  This presentation was on the trends of independently performed urologic procedural care by advanced practice providers over the last decade.  The authors hypothesized that both the percentage of independently performed urologic procedures was increasing. 
Read more ...

AUA 2016: Comparison of urinary tract infection rates associated with transurethral catheterization, suprapubic tube (SPT) and clean intermittent catheterization (CIC) in the postoperative setting: a network meta-analysis


The authors note that there are very few studies comparing these 3 methods of bladder drainage in the postoperative setting.  A network meta-analysis was performed of the available randomized controlled trials to elucidate the risk of UTIs associated with transurethral catheterization, suprapubic catheterization and clean intermittent catheterization in the postoperative setting. 
Read more ...

AUA 2016: Pervasive biofilm coverage: an analysis of biofilm information indwelling urinary catheters


These authors tried to quantify formation and progression of biofilm in urinary catheters of different duration dwell times.  74 catheters of different dwell times were collected from patients at the Duke University Medical Center.  These catheters were analyzed for biofilm formation.
Read more ...

AUA 2016: Oral cyclosporine for interstitial cystitis, efficacy, side effects and impact of clinical phenotype on outcomes


The AUA guideline on interstitial cystitis has identified Cyclosporine A as 5th tier therapy.  However, clinicians seldom use it due to concerns over side effects and efficacy.  Previous research on Cyclosporine did not clinically phenotype patients and often used Cyclosporine trough levels to determine drug exposure. 

Read more ...

AUA 2016: Contemporary practice patterns and voiding cystourethrograms (VCUG) use: The impact of evidence-based guidelines


Usage of voiding cystourethrogram (VCUG) from January 8, 2008 to August 2014 in one specific institution was presented.  In 2011, the American Academy of Pediatrics published revised guidelines on urinary tract infections in children age 12 to 24 months. 
Read more ...

AUA 2016: STENTRACKER: A Smartphone application for the prevention of “forgotten” retained ureteral stents (RUS)


San Diego, CA USA (UroToday.com) Forgotten and retained stents are a headache for urology practices and estimates are at 12%. This study describes the use of a novel smartphone platform or APP that facilitates data collection to present RUS.  
Read more ...